期刊文献+

西罗莫司洗脱支架与紫杉醇洗脱支架在糖尿病合并冠心病患者中运用的Meta分析 被引量:3

Sirolimus-eluting stents versus paclitaxel-eluting stents in diabetic patients with coronary artery disease-A meta-analysis of randomized controlled trials
下载PDF
导出
摘要 目的比较西罗莫司洗脱支架(Sirolimus-Eluting Stent,SES)和紫杉醇洗脱支架(Paclitaxel-Eluting Stent,PES)在糖尿病合并冠心病患者中运用的有效性和安全性。方法选取在2012年7月之前发表的关于比较西罗莫司洗脱支架和在紫杉醇洗脱支架在糖尿病合并冠心病患者中运用的临床随机对照试验研究(RCT),并应用Meta分析方法评估靶病变血运重建率,靶血管血运重建率,支架内血栓形成率等相关指标。结果共纳入8篇文献包括1 680名患者,其中851名患者接受西罗莫司洗脱支架,829名患者接受紫杉醇洗脱支架。Meta分析结果显示,SES组在靶病变血运重建(Target Lesion Revascularization,TLR)率(OR:0.53,95%CI:0.38~0.74,P=0.000 2)和靶血管血运重建(Target Vessel Revascularization,TVR)率(OR:0.70,95%CI:0.50~0.98,P=0.04)方面优于PES组,但在支架内血栓形成率(OR:0.91,95%CI:0.46~1.82,P=0.79)、死亡率(OR:0.95,95%CI:0.59~1.54,P=0.84)、心肌梗死率(OR:0.79,95%CI:0.46~1.38,P=0.41)方面两者无统计学差异。结论西罗莫司洗脱支架和紫杉醇洗脱支架在术后支架内血栓形成率、死亡率、心肌梗死率方面效果相当,但西罗莫司洗脱支架在降低靶病变血运重建率和靶血管血运重建率方面优于紫杉醇洗脱支架。 Objective To assess the efficacy and safety of sirolimus-eluting stent(SES)and paclitaxel-eluting stent(PES)in Diabetic Patients with Coronary Artery Disease.Methods We searched Cochrane Controlled Register Trials,Pubmed,Embase,Medline,Google scholar databases,CNKI,Wang Fang and VIP databases up to July 2012 to identify studies on SES versus PES in Diabetic Patients with Coronary Artery Disease,The Cochrane Collaboration's software RevMan 5.1 was used for Meta-analysis.Results No significant heterogeneity was seen across the 8 randomized trials for all analyzed events.Sirolimus-eluting stent was associated with a significant reduction in the risk of TLR(OR:0.53,95%CI:0.38~0.74,P=0.0002)and TVR(OR:0.70,95%CI:0.50~0.98,P=0.04).No significant differences were observed regarding the risk of death(OR:0.95,95%CI:0.59~1.54,P=0.84),myocardial infarction(OR:0.79,95%CI:0.46~1.38,P=0.41)and stent thrombosis(OR:0.91,95%CI:0.46~1.82,P=0.79).Conclusions In diabetic patients with coronary artery disease,SES leads a reduction in the risk of TLR and TVR compared with PES.But there is no differences in the risk of stent thrombosis,death and myocardial infarction.
出处 《安徽医药》 CAS 2013年第3期473-476,共4页 Anhui Medical and Pharmaceutical Journal
关键词 西罗莫司洗脱支架 紫杉醇洗脱支架 糖尿病 冠心病 META分析 sirolimus-eluting stents paclitaxel-eluting stents diabetes mellitus coronary artery Disease Meta-analysis
  • 相关文献

参考文献17

  • 1Jensen LO, Maeng M, Thayssen P, et al. Long-term outcomes after percutaneous coronary intervention in patients with and without dia- betes meUltus in Western Denmark [ J ]. Am J Cardiol, 2010,105 : 1513 -1519. 被引量:1
  • 2Patti G, Nusca A, Di Sciascio G. Meta-analysis comparison (nine tri- als) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus [ J ]. Am J Cardiol,2008,102 ( 10 ) : 1328 - 1334. 被引量:1
  • 3Dibra A, Kastrati A, Mehilli J, et al. Paclitaxel-eluting or sirolimus- eluting stents to prevent restenosis in diabetic patients[ J]. N Engl J Med,2005,353:663 - 670. 被引量:1
  • 4Billinger M, Beutler J, Taghetchian KR, et al. Two-year clinical out- come after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients [ J ]. Ear Heart J, 2008,29 ( 6 ) : 718 - 725. 被引量:1
  • 5Tomai F, Reimers B, De Luea L, et al. Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: a prospective, randomized, multicenter study[ J]. Diabetes Care,2008,31 : 15 - 19. 被引量:1
  • 6Maeng M, Jensen LO, Galloe AM, et al. Comparison of the sirolimus- eluting versus paclitaxel-eluting coronary stent in patients with dia- betes mellitus : the diabetes and drug-eluting stent (DiabeDES) ran- domized angiogTaphy trial [ J ]. Am J Cardiol,2009 ,103 :345 - 349. 被引量:1
  • 7Hong SJ, Kim MH, Cha KS, et al. Comparison of three-year clinical outcomes between sirolimus-versus paclitaxel-eluting stents in dia- betic patients : prospective randomized multicenter triM[ J ]. Catheter Cardiovasc Interv ,2010,76 (7) :924 - 933. 被引量:1
  • 8Briguori C, Airoldi F, Visconto G, et al. Novel approaches for Pre- venting or Limiting events in diabetic patients (NAPLES-DIABE- TES) triM: a randomized comparison of three drug-eluting stents in diabetic patients[ J]. Circ Cardiovasc Interv,2011,4:121 -129. 被引量:1
  • 9Lee SW, Park SW, Kim YH, et al. A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus:4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with DIABETES meUitus)trial[ J ]. JACC Cardiovasc Interv,2011,4(3) :310 -316. 被引量:1
  • 10Desch S, Schloma D, Mobius-Winkler S, et al. Randomized compari- son of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus: the LIP- SIA Yukon trial[ J ]. JACC Cardiovasc Interv, 2011,4 (4) : 452 - 459. 被引量:1

同被引文献39

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部